Oral Answers to Questions Debate

Full Debate: Read Full Debate
Department: Cabinet Office

Oral Answers to Questions

Ben Howlett Excerpts
Wednesday 2nd November 2016

(8 years ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness May of Maidenhead Portrait The Prime Minister
- Hansard - - - Excerpts

I can absolutely assure the hon. Gentleman that we are determined to get the best possible deal for the British people on exiting the European Union. We are looking at the various sectors and we are very conscious of the importance of the food and agricultural sector across the United Kingdom, particularly in Northern Ireland. We will do everything we can, including listening to representations made by the Northern Ireland Executive, to ensure that we get the best deal possible for our agri-food sector.

Ben Howlett Portrait Ben Howlett (Bath) (Con)
- Hansard - -

Q8. Last week’s announcement on the report on accelerated access to medicines will have a positive impact on the lives of children and adults with a rare genetic or undiagnosed condition. For decades, patients have struggled to get access to medicines in a timely fashion, and the work of my hon. Friend the Member for Mid Norfolk (George Freeman) made massive progress. Will the Prime Minister confirm that if the programme is successful with the first five to 10 drugs in the first year, it will be extended to further drugs in following years?

Baroness May of Maidenhead Portrait The Prime Minister
- Hansard - - - Excerpts

My hon. Friend is right to welcome the accelerated access review and to pay tribute to my hon. Friend the Member for Mid Norfolk (George Freeman), who has done so much to place life sciences in the UK on the agenda and to ensure that the UK develops as the best possible place to develop new drugs, which is exactly what we want to see. The Department of Health will look at the review’s recommendations and respond to them shortly. This is an important development in our ability to accelerate access to drugs, which is to the benefit of patients.